• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.67% Nasdaq Up 1.47%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    0.46 Down 0.01(1.75%) May 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.46
    Open:0.46
    Bid:0.27 x 7400
    Ask:0.44 x 3000
    1y Target Est:4.63
    Beta:3.15
    Earnings Date:Aug 12 - Aug 17 (Est.)
    Day's Range:0.46 - 0.47
    52wk Range:0.45 - 3.98
    Volume:1,351,002
    Avg Vol (3m):1,069,110
    Market Cap:14.21M
    P/E (ttm):N/A
    EPS (ttm):-0.79
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIDown 1.75%14.21M
    ALNYUp 2.15%11.01B
    MRNADown 3.70%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):203.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.35
    Quarterly EPS Est (Jun-15) :-0.10
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback